Category : Public Health, Disease Prevention & Wellness

Groundbreaking results from two NECTAR trials to be presented at TCT 2025 Neurotronic, Inc., a developer of multi-organ denervation to treat complex cardiovascular and metabolic disease,...

Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and...

First and only prospective blinded data confirm the Merlin CP-GEP (Clinico pathological-Gene Expression Profiling) Test accurately stratifies melanoma patients by sentinel node metastasis risk, showing a...

Oshi Access+ delivers turn-key clinical staffing to local GI practices and expands access to virtual multidisciplinary care, allowing physicians to practice at the top of...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced 96-week findings from PASO DOBLE (GeSIDA...

Critical Path Institute® (C-Path) today announced the official launch of the Critical Path Disease Modeling Coalition (CP-DMC) on pediatric inflammatory bowel disease (pIBD). This is a...

Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition” or the “Company”), a commercial-stage biopharmaceutical company focused on developing therapies for neurodegenerative diseases, today announced it will...

– New Data Showcase Safety Profile of Twice-Yearly Lenacapavir for Pre-Exposure Prophylaxis (PrEP) with Other Medications and Recruitment Strategies for PURPOSE 5 – – Five-Year BICSTaR Results...

Powered by the NC° Menopause Algorithm, the new app mode goes beyond symptom tracking to deliver science-backed, personalized insights for women navigating the menopausal transition...

The WHO Foundation and Lilly have announced a collaboration to financially support the aims of the World Health Organization’s global action plan on the public...

–        The program focuses on antibiotic resistance in urinary tract infections (UTI-DR), with applications open until November 20; final awardees to be announced in August 2026–        Selected...

AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, announces today that two of its senior leaders will serve as featured...

Acquisition strengthens Merck’s cardio-pulmonary portfolio with addition of Ohtuvayre® (ensifentrine), a first-in-class COPD maintenance treatment, that is expected to grow into the next decade Merck (NYSE:...

Becomes Fourth Affiliation in Newly Formed Chapters Health West Division Chapters Health System, the nation’s leading chronic illness innovator and largest nonprofit hospice network, today...

Asabys Partners, a Spanish venture capital firm specialized in healthcare, and AltamarCAM Partners, a global investment firm specialized in private markets, have today agreed to integrate Aliath...